profile

T2B Monthly

The Outsider Advantage: Cross-Industry Comms Insights

Published about 2 months ago • 1 min read

Hi!

As we know all too well, life sciences comms comes with a unique set of complexities, from regulatory constraints, to deep investor scrutiny, to audiences with technical expectations.

But many of the challenges we face aren’t truly one-of-a-kind to our sector. Across industries, communicators wrestle with trust, ambiguity, executive counsel under pressure, and shifting stakeholder dynamics.

Our March Comm Convo brings together communicators who have worked in and out of life sciences to share what they've learned in translation and where outside perspectives can complement our expertise.

March Comm Convo – The Outsider Advantage: Cross-Industry Comms Insights

📅 Thursday, March 26th @ Noon 1 p.m. ET / 9-10 a.m. PT / 5-6 p.m. GMT

T2B Pro & Student members (FREE): Log into your T2B account and access your promo code here.
T2B Basic members ($40): RSVP here.

Featured speakers:

💬 Lilian Anekwe, Director of Global Digital Communications, GSK​
Lilian blends deep scientific expertise with digital storytelling and strategic leadership. A former journalist and Content Curator at Facebook (Meta), her work spans digital transformation, social media, and strategic communications at one of the world’s largest biopharma companies.

💬 Alexandra Engel, Vice President, Corporate Communications, Axon​
Alex currently serves as VP and head of public relations at Axon, a global leader in public safety technology. Previously, she held leadership roles in Corporate Affairs at AstraZeneca and GSK. She helps organizations navigate growth, crisis, and complexity with credibility and clarity.

💬 Kathleen Noonan, VP, Head of Corporate Communications, ITM (Moderator)​
Kathleen’s career bridges European and Silicon Valley communications leadership, including roles at Microsoft, Siemens Energy, General Electric, Oracle, and now at ITM (Isotope Technologies Munich). She has deep experience shaping strategic narratives across tech, healthcare, and the industrial sectors.

Together, the speakers at our March Comm Convo will explore how stepping outside of the life sciences, and then back into it, can uncover fresh insights, strengthen judgment, and elevate how we advise leaders, engage audiences, and build trust.

Lynnea

​
​

T2B Monthly

What we're hearing from our communicator community

Read more from T2B Monthly

Hi! A quick reminder that tomorrow we’ll hold our Q2 Patient Advocacy & Engagement Roundtable event. This conversation will look at how biopharma communications are actually experienced by patient organizations... where messaging resonates, where it falls short, and what helps build stronger, more trusted relationships over time. Our speakers will share perspectives on what patient advocacy groups need from biopharma communicators, including how trust is built in practice, what makes...

4 days ago • 1 min read

Hi, Our Q1 masterclass explored what it means for biopharma communicators to show up fully as strategic partners, focusing on how we understand the business, structure our work, and make our impact more visible. Andrea Johnston led the session, bringing a builder’s perspective shaped by 30+ years across corporate, agency, and entrepreneurship (including one of the OG firms in our industry, Pure Communications). Here are 10 takeaways that stood out: Understand the economics of your clients' or...

6 days ago • 2 min read

Hi! Patient organizations are the closest link to the communities biopharma aims to serve. They see firsthand how messaging lands, including where it resonates, where it misses, and where it creates unintended friction. Our upcoming Patient Advocacy & Engagement Roundtable event brings together leaders across patient advocacy, healthcare communications, and patient-centered innovation to share how biopharma communications are experienced on the receiving end. What Patient Advocacy...

10 days ago • 1 min read